One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1093/annonc/mdz420.001
Copy DOI Publication Date: Nov 1, 2019 | |
 Citations: 6 |  License type: publisher-specific-oa |
Affiliation: Samsung Medical Center, Merck (Germany), Centre Hospitalier Universitaire de Toulouse, Hôpital Larrey, National Cancer Center, Saitama Cancer Center, Centre Hospitalier Universitaire de Bordeaux, University of Lille, Kurume University Hospital, Kosin University Gospel Hospital, Yonsei University, Severance Hospital, Tottori University Hospital, Vall d'Hebron Hospital Universitari, The University of Texas MD Anderson Cancer Center, Nagoya University, Asklepios Fachkliniken München-Gauting, Taipei Veterans General Hospital, Instituto Oncológico Dr. Rosell, Memorial Sloan Kettering Cancer Center62O - Tepotinib in NSCLC patients harboring METex14 skipping: Cohort A of phase II VISION study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
